Advertisement

Topics

Bristol-Myers Squibb Company (BMY) Shares Sold by Berkeley Capital Partners LLC

15:45 EDT 24 Oct 2017 | Topix

Berkeley Capital Partners LLC cut its stake in Bristol-Myers Squibb Company by 28.0% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 5,262 shares of the biopharmaceutical company's stock after selling 2,046 shares during the period.

Original Article: Bristol-Myers Squibb Company (BMY) Shares Sold by Berkeley Capital Partners LLC

NEXT ARTICLE

More From BioPortfolio on "Bristol-Myers Squibb Company (BMY) Shares Sold by Berkeley Capital Partners LLC"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...